Zobrazeno 1 - 10
of 30
pro vyhledávání: '"B.O. Plasencia Garcia de Diego"'
Publikováno v:
European Psychiatry, Vol 65, Pp S284-S285 (2022)
Introduction Long-acting injectable antipsychotics (LAIs) hold an important place in the treatment of psychosis. Knowledge of the best way to administer LAIs is important to maximize the efficacy and minimize the side-effects Objectives To assess th
Externí odkaz:
https://doaj.org/article/3563374e7d0f44a5b21b054514f2db1b
Publikováno v:
European Psychiatry, Vol 65, Pp S285-S286 (2022)
Introduction Paliperidone Palmitate 3-month formulation (PP3M) has shown a significantly longer time to relapse compared to placebo, with similar efficacy and safety to Paliperidone Palmitate 1-month (PP1M). However, studies of longer duration are re
Externí odkaz:
https://doaj.org/article/72f6f69f566e436bb53f0ab2ba83c82f
Autor:
S.L. Romero Guillena, B.O. Plasencia Garcia De Diego, F. Gotor Sanchez-Luengo, J. Gómez González
Publikováno v:
European Psychiatry, Vol 65, Pp S788-S789 (2022)
Introduction Aripiprazole once-monthly is a long-acting intramuscular injectable formulation of aripiprazole. The starting dose can be administered by following one of two regimens: • One injection start: On the day of initiation, administer one in
Externí odkaz:
https://doaj.org/article/6a384812e03941a4bfe6a65b25990c5f
Publikováno v:
European Neuropsychopharmacology. 29:S75-S76
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::23238d28248f7def0a43f18b35084f07
https://doi.org/10.1016/j.euroneuro.2019.09.141
https://doi.org/10.1016/j.euroneuro.2019.09.141
Publikováno v:
European Neuropsychopharmacology. 29:S35-S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0bf856376bc75b6d7e508eaa0fececbb
https://doi.org/10.1016/j.euroneuro.2019.09.088
https://doi.org/10.1016/j.euroneuro.2019.09.088
Publikováno v:
European Neuropsychopharmacology. 27:S874-S875
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1b6df89dd83f0423ceabdd620912cde
https://doi.org/10.1016/s0924-977x(17)31566-3
https://doi.org/10.1016/s0924-977x(17)31566-3
Autor:
B.O. Plasencia Garcia de Diego, S.L. Romero Guillena, F. Gotor Sanchez-Luengo, R. Navarro, O. Santamaria
Publikováno v:
European Neuropsychopharmacology. 27:S847-S848
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::76d60a545daa64eec333a3571a06c48b
https://doi.org/10.1016/s0924-977x(17)31524-9
https://doi.org/10.1016/s0924-977x(17)31524-9
Publikováno v:
European Neuropsychopharmacology. 27:S929-S930
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e253a6cbb131e1aa8e8254af39122734
https://doi.org/10.1016/s0924-977x(17)31650-4
https://doi.org/10.1016/s0924-977x(17)31650-4
Autor:
B.O. Plasencia Garcia de Diego, F. Gotor Sanchez-Luengo, R. Navarro, O. Santamaria, S.L. Romero Guillena
Publikováno v:
European Neuropsychopharmacology. 26:S502-S503
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f9cd101fdd1f0c2a152aeeb3194abb56
https://doi.org/10.1016/s0924-977x(16)31521-8
https://doi.org/10.1016/s0924-977x(16)31521-8
Publikováno v:
European Neuropsychopharmacology. 26:S675-S676
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b708e32567744d8555d9e8b3c17eee4
https://doi.org/10.1016/s0924-977x(16)31794-1
https://doi.org/10.1016/s0924-977x(16)31794-1